Lexicon Pharmaceuticals, Inc. (LXRX)

Lexicon Pharmaceuticals Statistics

Total Valuation

LXRX has a market cap or net worth of $519.66 million. The enterprise value is $460.22 million.

Market Cap	519.66M
Enterprise Value	460.22M

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

LXRX has 363.40 million shares outstanding. The number of shares has increased by 24.74% in one year.

Current Share Class	363.40M
Shares Outstanding	363.40M
Shares Change (YoY)	+24.74%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	1.21%
Owned by Institutions (%)	23.90%
Float	183.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.32
Forward PS	43.10
PB Ratio	4.32
P/TBV Ratio	6.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.49
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.47
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.37

Financial Efficiency

Return on equity (ROE) is -45.92% and return on invested capital (ROIC) is -14.79%.

Return on Equity (ROE)	-45.92%
Return on Assets (ROA)	-12.94%
Return on Invested Capital (ROIC)	-14.79%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$688,000
Profits Per Employee	-$665,796
Employee Count	103
Asset Turnover	0.27
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.17% in the last 52 weeks. The beta is 0.97, so LXRX's price volatility has been similar to the market average.

Beta (5Y)	0.97
52-Week Price Change	+20.17%
50-Day Moving Average	1.31
200-Day Moving Average	0.90
Relative Strength Index (RSI)	54.17
Average Volume (20 Days)	2,048,031

Short Selling Information

The latest short interest is 26.83 million, so 7.38% of the outstanding shares have been sold short.

Short Interest	26.83M
Short Previous Month	27.30M
Short % of Shares Out	7.38%
Short % of Float	14.59%
Short Ratio (days to cover)	8.97

Income Statement

In the last 12 months, LXRX had revenue of $70.86 million and -$68.58 million in losses. Loss per share was -$0.20.

Revenue	70.86M
Gross Profit	-12.94M
Operating Income	-54.57M
Pretax Income	-68.58M
Net Income	-68.58M
EBITDA	-53.92M
EBIT	-54.57M
Loss Per Share	-$0.20

Balance Sheet

The company has $115.95 million in cash and $56.51 million in debt, giving a net cash position of $59.44 million or $0.16 per share.

Cash & Cash Equivalents	115.95M
Total Debt	56.51M
Net Cash	59.44M
Net Cash Per Share	$0.16
Equity (Book Value)	120.16M
Book Value Per Share	0.33
Working Capital	144.95M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is -18.26%, with operating and profit margins of -77.00% and -96.77%.

Gross Margin	-18.26%
Operating Margin	-77.00%
Pretax Margin	-96.77%
Profit Margin	-96.77%
EBITDA Margin	-76.08%
EBIT Margin	-77.00%
FCF Margin	n/a

Dividends & Yields

LXRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.74%
Shareholder Yield	-24.74%
Earnings Yield	-13.20%
FCF Yield	n/a

Analyst Forecast

The average price target for LXRX is $3.23, which is 125.87% higher than the current price. The consensus rating is "Buy".

Price Target	$3.23
Price Target Difference	125.87%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	41.57%
EPS Growth Forecast (5Y)	-33.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 21, 2015. It was a reverse split with a ratio of 1:7.

Last Split Date	May 21, 2015
Split Type	Reverse
Split Ratio	1:7

Scores

Altman Z-Score	n/a
Piotroski F-Score	3